Is a complete MBRX research report available?

No complete published report is available for Moleculin Biotech, Inc. (MBRX) on this page. Market-directory data, when present, is not a substitute for a validated stock analysis.

Moleculin Biotech, Inc. (MBRX)

NASDAQ: MBRX · USD

$8.50

-0.77 (-8.3%)· Recorded snapshot

Market cap	8.3M
Net income (ttm)	-32.5M
EPS (ttm)	-$192
Shares out	973.9K
Volume	100,746
Beta	2.00

Market data

Price

Recent price action with selectable time range.

Financial snapshot

Net income (ttm): -32.5M
EPS (ttm): -$192
Market cap: 8.3M

Ticker	Name	Market cap	P/E	P/S	ROIC	5Y rev CAGR	1Y total return	Rating
EXAS	Exact Sciences Corp	—	—	—	—	—	—	Halten

Metric	Value
Amount currency	USD
CIK code	0001659617
Company name	Moleculin Biotech, Inc.
Country	United States
Country code	US
CUSIP number	60855D507
Earnings date	2026-11-12
Earnings time	amc
Employees	17
Employees change	-1
Employees growth	-5.56%
Enterprise value	$1.3M
Exchange	NASDAQ
Financial currency	USD
Financial report date	2026-06-30
First seen	2026-05-09
Fiscal year end	December
Founded	2015
Industry	Biotechnology
IPO date	2016-06-02
Is primary listing	Yes
Is SPAC	No
ISIN number	US60855D5077
Last 10-K release date	2026-03-18
Last earnings date	2026-08-14
Last refreshed	2026-10-28
Last stock split date	2026-10-20
Last stock split type	Reverse
Market cap	$8.3M
Market cap category	Nano-Cap
Next earnings date	2026-11-12
Options	No
Price	$8.50
Price currency	USD
Sector	Healthcare
SIC code	2834
Stock price date	2026-10-28
Symbol	MBRX
U.S. state	Texas
Website	https://moleculin.com

Metric

Value

Amount currency

USD

CIK code

0001659617

Company name

Moleculin Biotech, Inc.

Country

United States

Country code

CUSIP number

60855D507

Earnings date

2026-11-12

Earnings time

amc

Employees

Employees change

-1

Employees growth

-5.56%

Enterprise value

$1.3M

Exchange

NASDAQ

Financial currency

USD

Financial report date

2026-06-30

First seen

2026-05-09

Fiscal year end

December

Founded

2015

Industry

Biotechnology

IPO date

2016-06-02

Is primary listing

Yes

Is SPAC

ISIN number

US60855D5077

Last 10-K release date

2026-03-18

Last earnings date

2026-08-14

Last refreshed

2026-10-28

Last stock split date

2026-10-20

Last stock split type

Reverse

Market cap

$8.3M

Market cap category

Nano-Cap

Next earnings date

2026-11-12

Options

Price

$8.50

Price currency

USD

Sector

Healthcare

SIC code

2834

Stock price date

2026-10-28

Symbol

MBRX

U.S. state

Texas

Website

https://moleculin.com

Metric	Value
Earnings yield	-2,258.18%
FCF / EV yield	-2,094.75%
FCF yield	-309.97%
P/B ratio	0.28x
Price / tangible book value	18.63x
Sector forward P/E	23.56x
Sector P/E	50.13x

Metric

Value

Earnings yield

-2,258.18%

FCF / EV yield

-2,094.75%

FCF yield

-309.97%

P/B ratio

0.28x

Price / tangible book value

18.63x

Sector forward P/E

23.56x

Sector P/E

50.13x

Metric	Value
Profit per employee	$-1.9M
ROA	-84.57%
ROA (5Y)	-46.38%
ROCE	-245.24%
ROE	-1,371.64%
ROE (5Y)	-109.79%
ROIC	-703.03%

Metric

Value

Profit per employee

$-1.9M

ROA

-84.57%

ROA (5Y)

-46.38%

ROCE

-245.24%

ROE

-1,371.64%

ROE (5Y)

-109.79%

ROIC

-703.03%

Metric	Value
EPS growth quarters	10
EPS growth years	3
Net income growth quarters	1
Net income growth years	0
Revenue growth years	0

Metric

Value

EPS growth quarters

EPS growth years

Net income growth quarters

Net income growth years

Revenue growth years

Metric	Value
Depreciation and amortization	$47,000
EBIT	$-28.9M
EBITDA	$-28.8M
EPS	$-191.95
FCF per share	$-26.04
Financing cash flow	$25.1M
Free cash flow	$-25.4M
Free cash flow minus SBC	$-26.9M
Net cash flow	$-295,000
Net income	$-32.5M
Operating cash flow minus SBC	$-26.9M
Operating income	$-28.9M
Stock-based compensation	$1.6M

Metric

Value

Depreciation and amortization

$47,000

EBIT

$-28.9M

EBITDA

$-28.8M

EPS

$-191.95

FCF per share

$-26.04

Financing cash flow

$25.1M

Free cash flow

$-25.4M

Free cash flow minus SBC

$-26.9M

Net cash flow

$-295,000

Net income

$-32.5M

Operating cash flow minus SBC

$-26.9M

Operating income

$-28.9M

Stock-based compensation

$1.6M

Metric	Value
Book value per share	$32.64
Debt / equity	0.03
Interest coverage	-671.51
Long-term assets	$12.4M
Long-term liabilities	$187,000
Net cash (debt)	$7M
Net cash / market cap	85.2%
Net cash growth	-2.34%
Net debt / equity	-0.6
Piotroski F-Score	1
Property, plant and equipment	$316,000
Shareholders' equity	$11.6M
Tangible book value	$439,000
Tangible book value per share	$1.24
Total assets	$21.1M
Total cash	$7.3M
Total debt	$292,000
Total liabilities	$9.5M
WACC	15.14%

Metric

Value

Book value per share

$32.64

Debt / equity

0.03

Interest coverage

-671.51

Long-term assets

$12.4M

Long-term liabilities

$187,000

Net cash (debt)

$7M

Net cash / market cap

85.2%

Net cash growth

-2.34%

Net debt / equity

-0.6

Piotroski F-Score

Property, plant and equipment

$316,000

Shareholders' equity

$11.6M

Tangible book value

$439,000

Tangible book value per share

$1.24

Total assets

$21.1M

Total cash

$7.3M

Total debt

$292,000

Total liabilities

$9.5M

WACC

15.14%

Metric	Value
Current assets	$8.7M
Current liabilities	$9.3M
Current ratio	0.94
Net working capital	$-7.7M
Quick ratio	0.78
Working capital	$-590,000

Metric

Value

Current assets

$8.7M

Current liabilities

$9.3M

Current ratio

0.94

Net working capital

$-7.7M

Quick ratio

0.78

Working capital

$-590,000

Metric	Value
Buyback yield / dilution	-906.89%
Dividend yield	0%
Shareholder yield	-906.89%

Metric

Value

Buyback yield / dilution

-906.89%

Dividend yield

Shareholder yield

-906.89%

Metric	Value
10Y price change	-99.99%
10Y return CAGR	-62.24%
10Y total return	-99.99%
150-day SMA	$32.92
1D price change	-8.26%
1M price change	-27.65%
1M total return	-27.65%
1W price change	40.63%
1W total return	40.63%
1Y price change	-96.49%
1Y return CAGR	-96.5%
1Y total return	-96.49%
20-day SMA	$7.88
200-day SMA	$41.14
3M price change	-80.13%
3M total return	-80.13%
3Y price change	-99.76%
3Y return CAGR	-86.57%
3Y total return	-99.76%
50-day SMA	$10.97
50-day SMA vs 200-day SMA	50under200
52-week high	$315.00
52-week high date	2025-11-03
52-week low	$3.23
52-week low date	2026-08-03
5Y price change	-99.96%
5Y return CAGR	-78.72%
5Y total return	-99.96%
6M price change	-82.86%
6M total return	-82.86%
All-time high	$431,100.43
All-time high date	2016-06-06
All-time low	$3.23
All-time low date	2026-08-03
Average true range (ATR)	$1.29
Average volume	44.3K
Beta (1Y)	-0.94
Beta (2Y)	1.16
Beta (5Y)	2
Change from 52-week high	-97.3%
Change from 52-week low	163.32%
Change from all-time high	-100%
Change from all-time low	169.67%
Change from open	-8.7%
Day's gap	0.43%
Dollar volume	$856,341
High price	$10.05
Low price	$8.50
Monthly RSI	29.62
Open price	$9.31
Position in 52-week range	0%
Premarket change	1.67%
Premarket close	$9.27
Premarket price	$9.42
Premarket volume	2.8K
Previous close	$9.27
Price vs 150-day SMA	-74.18%
Price vs 20-day SMA	7.87%
Price vs 200-day SMA	-79.34%
Price vs 50-day SMA	-22.52%
Relative volume	2.3
RSI	47.59
Sharpe ratio	-1.62
Sharpe ratio (3Y)	-0.47
Sharpe ratio (5Y)	-0.52
Sortino ratio	-1.84
Sortino ratio (3Y)	-0.79
Sortino ratio (5Y)	-0.84
Volume	100.7K
Weekly RSI	32.24
YTD price change	-86.85%
YTD total return	-86.85%

Metric

Value

10Y price change

-99.99%

10Y return CAGR

-62.24%

10Y total return

-99.99%

150-day SMA

$32.92

1D price change

-8.26%

1M price change

-27.65%

1M total return

-27.65%

1W price change

40.63%

1W total return

40.63%

1Y price change

-96.49%

1Y return CAGR

-96.5%

1Y total return

-96.49%

20-day SMA

$7.88

200-day SMA

$41.14

3M price change

-80.13%

3M total return

-80.13%

3Y price change

-99.76%

3Y return CAGR

-86.57%

3Y total return

-99.76%

50-day SMA

$10.97

50-day SMA vs 200-day SMA

50under200

52-week high

$315.00

52-week high date

2025-11-03

52-week low

$3.23

52-week low date

2026-08-03

5Y price change

-99.96%

5Y return CAGR

-78.72%

5Y total return

-99.96%

6M price change

-82.86%

6M total return

-82.86%

All-time high

$431,100.43

All-time high date

2016-06-06

All-time low

$3.23

All-time low date

2026-08-03

Average true range (ATR)

$1.29

Average volume

44.3K

Beta (1Y)

-0.94

Beta (2Y)

1.16

Beta (5Y)

Change from 52-week high

-97.3%

Change from 52-week low

163.32%

Change from all-time high

-100%

Change from all-time low

169.67%

Change from open

-8.7%

Day's gap

0.43%

Dollar volume

$856,341

High price

$10.05

Low price

$8.50

Monthly RSI

29.62

Open price

$9.31

Position in 52-week range

Premarket change

1.67%

Premarket close

$9.27

Premarket price

$9.42

Premarket volume

2.8K

Previous close

$9.27

Price vs 150-day SMA

-74.18%

Price vs 20-day SMA

7.87%

Price vs 200-day SMA

-79.34%

Price vs 50-day SMA

-22.52%

Relative volume

2.3

RSI

47.59

Sharpe ratio

-1.62

Sharpe ratio (3Y)

-0.47

Sharpe ratio (5Y)

-0.52

Sortino ratio

-1.84

Sortino ratio (3Y)

-0.79

Sortino ratio (5Y)

-0.84

Volume

100.7K

Weekly RSI

32.24

YTD price change

-86.85%

YTD total return

-86.85%

Metric	Value
Float	838.7K
Float percentage	86.12%
Shares change (QoQ)	37.73%
Shares change (YoY)	906.89%
Shares held by insiders	6.69%
Shares held by institutions	2.45%
Shares outstanding	973.9K
Short % of float	24.39%
Short % of shares	21.01%
Short ratio	0.2 days

Metric

Value

Float

838.7K

Float percentage

86.12%

Shares change (QoQ)

37.73%

Shares change (YoY)

906.89%

Shares held by insiders

6.69%

Shares held by institutions

2.45%

Shares outstanding

973.9K

Short % of float

24.39%

Short % of shares

21.01%

Short ratio

0.2 days

Moleculin Biotech, Inc. (MBRX)

Price

Financial snapshot

Fair-value bridge

Latest news · MBRX

Valuation

Profitability

Balance sheet

Trading

Next earnings

Sector percentile context

All MBRX indicators

Profile and market data

Valuation

Profitability

Growth

Financial statements

Financial strength

Liquidity

Dividends and buybacks

Performance and technicals

Ownership and float

Deeper analysis on MBRX

Frequently asked questions